The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNegovsky Reanimatology Research Institute

About this trial

Total knee replacement (TKR) is considered the most effective and safe method of radical treatment of late stages of knee osteoarthritis. A well-known problem of TKR is a severe postoperative pain syndrome, which is observed in more than 50% of patients.

Femoral nerve block (FNB) is the "gold standard" for continuous postoperative analgesia after total knee replacement, as it is effective in reducing the frequency of use of opioid analgetics and reduce the duration of hospitalization. At the same time, the negative effect of this method is the motor blockade of the quadriceps femoris muscle which leads to functional impairment and is associated with an increased risk of falling.

Adductor canal block (ACB) provides adequate analgesia comparable to femoral nerve block. Moreover, ACB doesn't affect the motor function of the quadriceps femoris muscle.

The possibility of enhanced recovery after total knee replacement is the reason to compare single-shot adductor canal block and continuous femoral nerve block.

Eligibility criteria

Qualifiers

Age ≥ 18

Planned primary total knee replacement

Planned neuraxial anesthesia

Written informed consent

Disqualifiers

Urgent surgery

Planned revision total knee replacement

Known allergic reaction to anesthetics

Confirmed localized infection at the puncture sites

Trial design

Treatments tested in this trial

  • Single-shot adductor canal block
  • Continuous femoral nerve block

Treatment groups

220 Participants
are divided into 2 treatment groups